Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

BACKGROUND: Antiviral treatment of patients with chronic hepatitis B (CHB) in the grey zone of treatment comands risk management in order to optimize the health outcome. In this sense, the identification of HBV mutants related with an increased risk of hepatocellular carcinoma (HCC) could be useful...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Gil-García, Ana Isabel, Madejón, Antonio, Francisco-Recuero, Irene, López-López, Ana, Villafranca, Emiliana, Romero, Miriam, García, Araceli, Olveira, Antonio, Mena, Rocío, Larrubia, Juan Ramón, García-Samaniego, Javier
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2019
Assuntos:
Observational Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6801187/
https://ncbi.nlm.nih.gov/pubmed/31636479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i38.5883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados